NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Year-over-year earnings per share growth rate
Percentile
P8
Near historical low
vs 3Y Ago
-7.3x
Contraction
Streak
3 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -70.77% |
| Q3 2025 | 7.82% |
| Q2 2025 | 18.24% |
| Q1 2025 | 205.52% |
| Q4 2024 | -80.35% |
| Q3 2024 | 1.31% |
| Q2 2024 | 73.10% |
| Q1 2024 | 81.48% |
| Q4 2023 | -42.33% |
| Q3 2023 | -11.44% |
| Q2 2023 | 53.94% |
| Q1 2023 | 343.11% |
| Q4 2022 | 9.65% |
| Q3 2022 | -82.28% |
| Q2 2022 | 733.57% |
| Q1 2022 | -162.81% |
| Q4 2021 | 23.53% |
| Q3 2021 | -13.14% |
| Q2 2021 | 41.24% |
| Q1 2021 | -15.41% |
| Q4 2020 | -69.06% |
| Q3 2020 | 64.99% |
| Q2 2020 | 30.37% |
| Q1 2020 | -10.09% |
| Q4 2019 | -12.21% |
| Q3 2019 | -16.77% |
| Q2 2019 | 19.42% |
| Q1 2019 | -23.82% |
| Q4 2018 | -12.54% |
| Q3 2018 | 0.51% |
| Q2 2018 | -39.48% |
| Q1 2018 | 32.30% |
| Q4 2017 | 154.98% |
| Q3 2017 | -13.77% |
| Q2 2017 | -44.65% |
| Q1 2017 | -9.66% |
| Q4 2016 | 194.99% |
| Q3 2016 | 38.32% |
| Q2 2016 | -21.26% |
| Q1 2016 | 63.38% |